4//SEC Filing
Neville Everett 4
Accession 0001225208-23-007627
CIK 0001739940other
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 5:03 PM ET
Size
26.7 KB
Accession
0001225208-23-007627
Insider Transaction Report
Form 4
Neville Everett
See Remarks
Transactions
- Exercise/Conversion
Common Stock, $.01 Par Value
2023-07-19$192.02/sh+2,519$483,698→ 18,094 total - Sale
Common Stock, $.01 Par Value
2023-07-19$295.21/sh−13,157$3,884,078→ 4,937 total - Exercise/Conversion
Common Stock, $.01 Par Value
2023-07-20$213.80/sh+570$121,866→ 5,507 total - Exercise/Conversion
Common Stock, $.01 Par Value
2023-07-20$227.02/sh+219$49,717→ 5,987 total - Exercise/Conversion
Common Stock, $.01 Par Value
2023-07-19$213.80/sh+7,236$1,547,057→ 12,173 total - Exercise/Conversion
Common Stock, $.01 Par Value
2023-07-19$227.02/sh+3,402$772,322→ 15,575 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2023-07-20−261→ 0 totalExercise: $192.02From: 2021-02-26Exp: 2030-02-26→ Common Stock, $.01 Par Value (261 underlying) - Exercise/Conversion
Common Stock, $.01 Par Value
2023-07-20$192.02/sh+261$50,117→ 5,768 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2023-07-19−2,519→ 261 totalExercise: $192.02From: 2021-02-26Exp: 2030-02-26→ Common Stock, $.01 Par Value (2,519 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2023-07-19−7,236→ 4,474 totalExercise: $213.80From: 2022-03-01Exp: 2031-02-24→ Common Stock, $.01 Par Value (7,236 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2023-07-19−3,402→ 7,463 totalExercise: $227.02From: 2023-03-01Exp: 2032-02-23→ Common Stock, $.01 Par Value (3,402 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2023-07-20−570→ 3,904 totalExercise: $213.80From: 2022-03-01Exp: 2031-02-24→ Common Stock, $.01 Par Value (570 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2023-07-20−219→ 7,244 totalExercise: $227.02From: 2023-03-01Exp: 2032-02-23→ Common Stock, $.01 Par Value (219 underlying)
Footnotes (4)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2022 and amended on February 7, 2023.
- [F2]This option was granted on February 26, 2020. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.
- [F3]This option was granted on February 24, 2021 and vests in three equal annual installments. The first two installments became exercisable on March 1, 2022 and March 1, 2023, and the last installment becomes exercisable on March 1, 2024.
- [F4]This option was granted on February 23, 2022, and vests in three equal annual installments. The first installment became exercisable on March 1, 2023, and the next two installments become exercisable on March 1, 2024 and March 1, 2025.
Documents
Issuer
Cigna Group
CIK 0001739940
Entity typeother
Related Parties
1- filerCIK 0001641142
Filing Metadata
- Form type
- 4
- Filed
- Jul 20, 8:00 PM ET
- Accepted
- Jul 21, 5:03 PM ET
- Size
- 26.7 KB